← Torna agli articoli

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH affidabilità neutral tono

Copertura (33 articoli)

Oncology Central · Oct 01, 2026

Early psychotherapy for depression linked to 21% lower cancer mortality

A large study of 265,000 cancer patients found depression increases cancer mortality risk by 11%, but psychotherapy within 4 weeks of diagnosis reduces cancer-specific mortality by 21%. Only 3% of depressed cancer patients received early psychotherapy.

News-Medical · Oct 01, 2026

GLP-1 drugs show real-world benefits in European children with type 2 diabetes

Research from Germany, Austria, and Luxembourg shows GLP-1 receptor agonist use in children and young people with type 2 diabetes has surged from 6.3% in 2019 to 27.2% in 2025, with real-world data confirming significant health benefits including weight reduction and improved glycemic control.

respiratory-therapy.com · Oct 01, 2026

Severe Pneumonia May Unmask Undiagnosed Blood Cancer in Adults

A Swedish study found that one-in-four hospitalized pneumococcal disease patients showed M protein markers linked to blood cancer, suggesting routine screening could identify undiagnosed malignancies and immunodeficiencies.

AJMC · Oct 01, 2026

Routine Blood Test Ratio Predicts Mortality Risk in CKD Patients

A higher ratio of red blood cell distribution width to albumin (RAR) from routine blood tests is independently linked to increased mortality risk from all causes, cardiovascular disease, and cancer in adults with chronic kidney disease.

Pagina 1 di 2 Successiva →
Contattaci Domande frequenti